Peter is founder and Chief Executive Officer of Grey Wolf, setting up the company in 2017 with Tom McCarthy, Executive Chairman, and also co-founder of Pathios Therapeutics and ThirtyFiveBio. Peter is an accomplished drug discovery executive with over 19 years of experience in biomedical research leading drug discovery projects across disease areas.

Prior to Grey Wolf he was at Vertex Pharmaceuticals, where he led drug discovery projects and had responsibility for leading a number of target identification teams, and before Vertex he was a research fellow at the Medical Research Council investigating the pathophysiology and underlying mechanisms of neurodegeneration and publishing multiple first and co-author publications. Peter holds a PhD in Biochemistry and Molecular Genetics from the University of Bristol and a BSc in Biochemistry.